Dimitris Voliotis - Insider Trading & Ownership

Location
C/O Zentalis Pharmaceuticals, Inc., 530 Seventh Avenue, Suite 2201, New York, NY
Summary
The estimated net worth of Dimitris Voliotis is at least $1.32M dollars as of February 14, 2022. Dimitris Voliotis is the SVP, Clinical Development of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $1.32M.
Signature
/s/ Melissa B. Epperly, Attorney-in-Fact for Dimitris Voliotis
All Insider Reports
All Insider Reports

Email me when Dimitris Voliotis files a new Ownership 3,4,5 report.

⭐ Subscribe ⭐

Ownership of Dimitris Voliotis

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZNTL Zentalis Pharmaceuticals, Inc. SVP, Clinical Development $1.32M Feb 10, 2022

Insider Transactions Reported by Dimitris Voliotis:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.